3.15

0.32% -0.01

After Hours: 3.25 0.10 +3.17%

Achieve Life Sciences Inc (ACHV)

Overview News Price History Option Chain Financials Why ACHV Down? Discussions Forecast Stock Split

Achieve Life Sciences Inc stock is traded at $3.15, with a volume of 151.03K. It is down -0.32% in the last 24 hours and up +32.35% over the past month. Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.

Previous Close:

$3.16

Open:

$3.2

24h Volume:

151.03K

Relative Volume:

0.78

Market Cap:

$109.27M

Revenue:

Net Income/Loss:

$-32.94M

P/E Ratio:

-2.8378

EPS:

-1.11

Net Cash Flow:

$-24.95M

1W Performance:

+0.32%

1M Performance:

+32.35%

6M Performance:

-29.84%

1Y Performance:

-41.23%

1-Day Range:

$3.06

$3.20

1-Week Range:

$2.89

$3.20

52-Week Range:

$1.84

$5.59

Achieve Life Sciences Inc Stock (ACHV) Company Profile

Name

Achieve Life Sciences Inc

Sector

Healthcare (1171)

Industry

Biotechnology (672)

Phone

425-686-1500

Address

22722 29TH DR. SE, SEATTLE, BC

Employee

Twitter

Next Earnings Date

2025-03-11

Latest SEC Filings

ACHV's Discussions on Twitter

Compare ACHV with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ACHV Achieve Life Sciences Inc	3.15	108.91M	0	-32.94M	-24.95M	-1.11
ONC Beigene Ltd Adr	240.41	25.57B	3.81B	-644.79M	-669.77M	-6.24
VRTX Vertex Pharmaceuticals Inc	445.10	111.79B	11.10B	-988.90M	-1.26B	-3.92
AKTX Akari Therapeutics Plc Adr	1.30	39.90M	0	0	0	0.00
REGN Regeneron Pharmaceuticals Inc	591.85	65.28B	14.09B	4.50B	2.96B	39.28
VRNA Verona Pharma Plc Adr	73.93	6.31B	0	-153.72M	-103.81M	-2.00

Achieve Life Sciences Inc Stock (ACHV) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-14-24	Initiated	Rodman & Renshaw	Buy
Sep-27-24	Initiated	Raymond James	Strong Buy
May-10-23	Reiterated	Maxim Group	Buy
Jun-23-21	Initiated	Oppenheimer	Outperform

Achieve Life Sciences Inc Stock (ACHV) Latest News

08:41 AM

Achieve Life Sciences to Present at the Jefferies Global Healthcare Conference - GlobeNewswire

08:41 AM

08:04 AM

Achieve Life Sciences, Inc. (NASDAQ:ACHV) Shares Purchased by Northern Trust Corp - Defense World

08:04 AM

May 23, 2025

Shay Capital LLC Sells 425,000 Shares of Achieve Life Sciences, Inc. (NASDAQ:ACHV) - MarketBeat

May 23, 2025

May 20, 2025

ACHV: New Insights from ORCA-3 Study to Be Shared at 2025 Conference | ACHV Stock News - GuruFocus

May 20, 2025

Achieve Life Sciences to Present New Data at the 2025 ATS International Conference Demonstrating that Cytisinicline Reduced Cravings and Nicotine Intake | ACHV Stock News - GuruFocus

May 20, 2025

Achieve Life Sciences to Present Phase 3 Study Findings on Cytisinicline for Smoking Cessation at 2025 ATS Conference - Nasdaq

May 20, 2025

Achieve Life Sciences to Present New Data at the 2025 ATS - GlobeNewswire

May 20, 2025

Achieve Life Sciences to Present New Data at the 2025 ATS International Conference Demonstrating that Cytisinicline Reduced Cravings and Nicotine Intake - The Globe and Mail

May 20, 2025

May 18, 2025

Brokers Offer Predictions for ACHV Q3 Earnings - Defense World

May 18, 2025

May 16, 2025

Tower Research Capital LLC TRC Acquires 4,905 Shares of Achieve Life Sciences, Inc. (NASDAQ:ACHV) - Defense World

May 16, 2025

What is Zacks Small Cap’s Estimate for ACHV Q2 Earnings? - Defense World

May 16, 2025

May 15, 2025

Achieve Life Sciences targets NDA submission for cytisinicline in June 2025 as open label study hits key milestones - MSN

May 15, 2025

May 14, 2025

Raymond James Financial Inc. Purchases New Position in Achieve Life Sciences, Inc. (NASDAQ:ACHV) - MarketBeat

May 14, 2025

Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q1 2025 Earnings Call Transcript - Insider Monkey

May 14, 2025

ACHV: Kicking Butts to Achieve June NDA Filing - Yahoo Finance

May 14, 2025